BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9845587)

  • 1. Gastrin and the enterochromaffin-like cell: an acid update.
    Kidd M; Modlin IM; Tang LH
    Dig Surg; 1998; 15(3):209-17. PubMed ID: 9845587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
    Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
    Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion.
    Cui G; Waldum HL
    World J Gastroenterol; 2007 Jan; 13(4):493-6. PubMed ID: 17278212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation.
    Kidd M; Modlin IM; Black JW; Boyce M; Culler M
    Regul Pept; 2007 Oct; 143(1-3):109-17. PubMed ID: 17531331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological significance of ECL-cell histamine.
    Andersson K; Chen D; Mattsson H; Sundler F; Håkanson R
    Yale J Biol Med; 1998; 71(3-4):183-93. PubMed ID: 10461351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin-physiological and pathophysiological role: clinical consequences.
    Waldum HL; Brenna E; Kleveland PM; Sandvik AK
    Dig Dis; 1995; 13(1):25-38. PubMed ID: 7606834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of acid secretion.
    Schubert ML; Shamburek RD
    Gastroenterol Clin North Am; 1990 Mar; 19(1):1-25. PubMed ID: 1691738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal gastric acid secretion in man: a concept that needs precision.
    Waldum HL; Brenna E; Sandvik AK
    Scand J Gastroenterol; 1998 Oct; 33(10):1009-15. PubMed ID: 9829352
    [No Abstract]   [Full Text] [Related]  

  • 9. The cellular localization of the cholecystokinin 2 (gastrin) receptor in the stomach.
    Waldum HL; Kleveland PM; Sandvik AK; Brenna E; Syversen U; Bakke I; Tømmerås K
    Pharmacol Toxicol; 2002 Dec; 91(6):359-62. PubMed ID: 12688379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of isolated gastric enterochromaffin-like cells.
    Zeng N; Sachs G
    Yale J Biol Med; 1998; 71(3-4):233-46. PubMed ID: 10461355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Enterochromaffin-like [ECL] Cell-Central in Gastric Physiology and Pathology.
    Waldum HL; Sørdal ØF; Mjønes PG
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mastomys ECL cell function by transforming growth factor alpha.
    Lawton GP; Tang L; Kidd M; Chinery R; Miu K; Modlin IM
    J Surg Res; 1996 Feb; 60(2):293-302. PubMed ID: 8598657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
    Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
    Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a histamine H1 receptor antagonist on gastric endocrine cell proliferation induced by chronic acid suppression in rats.
    Chen G; Kashiwagi H; Omura N; Aoki T
    J Gastroenterol; 2000; 35(10):742-7. PubMed ID: 11063217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of ECL cells and gastric neoplasia.
    Waldum HL; Brenna E; Sandvik AK
    Yale J Biol Med; 1998; 71(3-4):325-35. PubMed ID: 10461363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric functions in gastrin gene knock-out mice.
    Friis-Hansen L
    Pharmacol Toxicol; 2002 Dec; 91(6):363-7. PubMed ID: 12688380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHRONIC USE OF PROTON PUMP INHIBITORS AND THE QUANTITY OF G, D, AND ECL CELLS IN THE STOMACH.
    Camilo SMP; Almeida ÉCS; Sousa JB; Camilo LP; Etchebehere RM
    Arq Bras Cir Dig; 2020; 33(2):e1506. PubMed ID: 32844883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.
    Hirschowitz BI
    Yale J Biol Med; 1992; 65(6):659-76; discussion 689-92. PubMed ID: 1341070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole: its influence on gastric acid secretion, gastrin and ECL cells.
    Larsson H; Håkanson R; Mattsson H; Ryberg B; Sundler F; Carlsson E
    Toxicol Pathol; 1988; 16(2):267-72. PubMed ID: 3187355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.